Tenax Therapeutics Inc. Watch

EX-10.1

from 8-K 1 page Amendment No. 2 to the Tenax Therapeutics, Inc. 2022 Stock Incentive Plan

12/34/56

EX-10.2

from 8-K 24 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 40 pages Securities Purchase Agreement

12/34/56

EX-10.2

from 8-K 4 pages Amendment to Executive Employment Agreement

12/34/56

EX-10.1

from 8-K 1 page Amendment No. 1 to the Tenax Therapeutics, Inc. 2022 Stock Incentive Plan

12/34/56

EX-10.1

from 8-K 5 pages Certain Information Identified With the Mark “[***]” Has Been Excluded From This Exhibit Because Such Information Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed Third Amendment to the License Agreement of September 20, 2013

12/34/56

EX-10.2

from 8-K 30 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 15 pages Placement Agency Agreement February 8, 2024

12/34/56

EX-10.26

from S-1/A 16 pages Placement Agency Agreement [•], 2024

12/34/56

EX-10.25

from S-1/A 31 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 3 pages Lease Termination Agreement

12/34/56

EX-10.3

from 8-K 4 pages Leak-Out Agreement

12/34/56

EX-10.2

from 8-K 27 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 16 pages Placement Agency Agreement February 3, 2023

12/34/56

EX-10.30

from S-1/A 5 pages Leak-Out Agreement

12/34/56

EX-10.29

from S-1/A 27 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 2 pages [Signature Page Follows] 1

12/34/56

EX-10.2

from 8-K 10 pages Tenax Therapeutics, Inc. 2022 Stock Incentive Plan Notice of Stock Option Grant

12/34/56

EX-10.1

from 8-K 23 pages Tenax Therapeutics, Inc. 2022 Stock Incentive Plan 2022 Stock Incentive Plan Approved by the Board and Stockholders on April 8, 2022 and June 9, 2022, Respectively

12/34/56

EX-10.2

from 8-K 22 pages Registration Rights Agreement

12/34/56